Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seetharama Satyanarayanajois

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Immunotherapy|September 5, 2014
Peptides and peptidomimetics as immunomodulatorsAmeya S Gokhale, Seetharama Satyanarayanajois
Biopolymers|November 14, 2013
Structure-activity relationships of peptidomimetics that inhibit PPI of HER2-HER3Shanthi Kanthala, Ted Gauthier, Seetharama Satyanarayanajois
Pharmaceutical Research|November 17, 2006
Aqueous-soluble, non-reversible lipid conjugate of salmon calcitonin: synthesis, characterization and in vivo activityWeiqiang Cheng, Seetharama Satyanarayanajois, Lee-Yong Lim
Journal of Biomolecular Structure & Dynamics|June 27, 2012
Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimeticSashikanth Banappagari, Miriam Corti, Seth Pincus, et al.
Chemical Biology & Drug Design|August 26, 2009
Design, synthesis, and docking studies of peptidomimetics based on HER2-herceptin binding site with potential antiproliferative activity against breast cancer cell linesSeetharama Satyanarayanajois, Stephanie Villalba, Liu Jianchao, et al.
Chemical Biology & Drug Design|March 28, 2013
Immunosuppression by co-stimulatory molecules: inhibition of CD2-CD48/CD58 interaction by peptides from CD2 to suppress progression of collagen-induced arthritis in miceAmeya Gokhale, Shanthi Kanthala, John Latendresse, et al.
European Journal of Medicinal Chemistry|May 22, 2013
Design, synthesis and characterization of peptidomimetic conjugate of BODIPY targeting HER2 protein extracellular domainSashikanth Banappagari, Alecia McCall, Krystal Fontenot, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Immunotherapy|September 5, 2014
Peptides and peptidomimetics as immunomodulatorsAmeya S Gokhale, Seetharama Satyanarayanajois
Biopolymers|November 14, 2013
Structure-activity relationships of peptidomimetics that inhibit PPI of HER2-HER3Shanthi Kanthala, Ted Gauthier, Seetharama Satyanarayanajois
Pharmaceutical Research|November 17, 2006
Aqueous-soluble, non-reversible lipid conjugate of salmon calcitonin: synthesis, characterization and in vivo activityWeiqiang Cheng, Seetharama Satyanarayanajois, Lee-Yong Lim
Journal of Biomolecular Structure & Dynamics|June 27, 2012
Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimeticSashikanth Banappagari, Miriam Corti, Seth Pincus, et al.
Chemical Biology & Drug Design|August 26, 2009
Design, synthesis, and docking studies of peptidomimetics based on HER2-herceptin binding site with potential antiproliferative activity against breast cancer cell linesSeetharama Satyanarayanajois, Stephanie Villalba, Liu Jianchao, et al.
Chemical Biology & Drug Design|March 28, 2013
Immunosuppression by co-stimulatory molecules: inhibition of CD2-CD48/CD58 interaction by peptides from CD2 to suppress progression of collagen-induced arthritis in miceAmeya Gokhale, Shanthi Kanthala, John Latendresse, et al.
European Journal of Medicinal Chemistry|May 22, 2013
Design, synthesis and characterization of peptidomimetic conjugate of BODIPY targeting HER2 protein extracellular domainSashikanth Banappagari, Alecia McCall, Krystal Fontenot, et al.
Pageof 1